Unique Swedish diabetes study shows how insulin pumps impact quality of life
Being treated for diabetes with an insulin pump, an aid that is attached to the body to provide a continuous supply of insulin, has a strong impact on a person’s quality of life.
The pump can be a lifeline, but also a bothersome shackle. This is shown in a unique long-term study performed at the Academy of Health and Society, Dalarna University, Falun, Sweden in collaboration with the Clinic of Internal Medicine at Falun Hospital as well as Uppsala University and Umeå University.
The finding is part of a larger study where, for four years, researchers followed a group of adults with type-1 diabetes being treated with an insulin pump. The group’s blood glucose levels, in terms of HbA1c, and their satisfaction with the treatment were examined via blood samples and surveys, respectively.
The researchers then continued their long-term monitoring with interviews, after the subjects had been using an insulin pump for more than five years. The qualitative interview method has come to be a more and more important complement to traditional research methods in recent years.
There have only been a few such studies in the world. Qualitative methods yield a good picture of how the individual perceives and deals with his/her everyday life with a life-long disorder.
The results of the interviews evinced a pattern that could be divided into various themes. The insulin pump was perceived to be a lifeline in the sense that it brought greater independence, greater control of the subject’s own life situation, and that life had become normalized. On the other hand, the pump was perceived as being a shackle, meaning that the subject was dependent on the technology, felt stigmatized, and was weighed down by the disease. Among interviewees, some had a generally favorable view of the treatment with an insulin pump, while others oscillated between a favorable and an unfavorable view, with a third group expressing a predominantly negative view. These themes and views could not be related to blood glucose levels, which indicate that it is not enough to measure health based solely on medical examination methods. To get a better understanding of, and a more holistic picture of health and quality of life, it is necessary to analyze narratives from the individual subjects’ own perceptions, both as medical parameters and as health surveys.
In the interviews Janeth Leksell, one of the researchers and a lecturer at the Falun campus of Dalarna University, could hear descriptions of the insulin pump like the following:
- My first step toward better self-esteem
- The pump means freedom and flexibility
- I like dresses that show your figure, but it’s hard to wear them with a pump. At home I often put the pump in my bra, so I have three breasts.
- The pump can feel like a shackle. You feel you’re locked into something.
Caring staff needs to be conscious of how the insulin pump affects the everyday lives of patients, lives that are not only about diabetes. The findings of this study may provide guidance and a platform for diabetes nurses and physicians when they meet with and try to support patients living with insulin pumps, according to Anna Garmo, the diabetes nurse who directed the study.
Questions: Anna Garmo, Diabetes nurse, Clinic of Internal Medicine, Falun Hospital,
email@example.com, Mobile: +46 (0)70-227 60 64
Pressofficer Hannes Forsell, firstname.lastname@example.org and +46-23 778 116
Publication: Garmo. A, Hörnsten. A, Leksell. J 'The pump was a saviour for me.' Patients' experiences of insulin pump therapy.
Diabet Med, 2013 Feb 8. doi: 10.1111/dme.12155. [Epub ahead of print].
46 adults with type-1 diabetes who switched from treatment with multiple-daily injections with insulin pens to an insulin pump were monitored for glycaemic control and treatment satisfaction, Garmo A, Garmo H, Ärnlöv J, Leksell J. Long-term treatment effects of insulin pump therapy. Pract Diab Int 2011; 28: 295–299. The authors conclude that both glycaemic control and treatment satisfaction improved and remained at the improved level during the four-year follow-up period, following the switch to an insulin pump.
In the spring of 2009, 16 of the participants in the earlier study were interviewed, all having used an insulin pump for 5–9 years. At the time of the interview, the subjects were aged 29–65 years. The purpose was to find out their perceptions of insulin pump treatment in everyday life. The interviews took 30–45 minutes and were analyzed using qualitative content analysis as laid down by Graneheim & Lundman.
The findings show that the pump can be experienced both as a lifeline and as a shackle. Good or unsatisfactory glycaemic control does not seem to have any association with these perceptions.
The subjects could be divided into three groups. HbA1c in the group that had a positive view of insulin pump treatment varied between 41-70 mmol/mol. In the group with a negative view, HbA1c varied between 32-72 mmol/mol, and in the group with more mixed views, HbA1c varied between 47-68 mmol/mol. However, the number of subjects is so limited that no far-reaching conclusions can be drawn. Nevertheless, the findings do indicate that analysis of glycaemic control does not reveal everything about a patient’s quality of life.
Hannes Forsell | idw